Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis

(2010) Randi Y. Leavitt et al.   ARTHRITIS AND RHEUMATISM

Mycophenolate Mofetil for Induction and Maintenance of Remission in Microscopic Polyangiitis with Mild to Moderate Renal Involvement--A Prospective, Open-Label Pilot Trial

(2010) F. Silva et al.   Clinical Journal of the American Society of Nephrology

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab-Associated Neutropenia

(2010) Kieron Dunleavy et al.   SEMINARS IN HEMATOLOGY

Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis

(2010) Boris Hugle et al.   ARTHRITIS CARE & RESEARCH

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood

(2008) A. J. Ferraro et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum Immunoglobulins and Risk of Infection: How Low Can You Go?

(2008) Daniel E. Furst   SEMINARS IN ARTHRITIS AND RHEUMATISM